Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mecasermin rinfabate

EU orphan designation number: EU/3/06/399   
Active ingredient: Mecasermin rinfabate
Indication: Prevention of retinopathy of prematurity in neonates of less than 32 weeks of gestational age
Sponsor: Premacure AB
Dag Hammarskjölds väg 60, 751 83 Uppsala, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2006 Orphan designation EMEA/OD/031/06 (2006)3922 of 28/08/2006
01/10/2007 Change of name and/or address of sponsor